NCT05229939

Brief Summary

Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native kidneys, but their performances in transplant kidney population remains unknown. We aimed at developing a kidney-transplant-specific GFR equation, and comparing its performance to standard GFR equations.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,412

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2000

Longer than P75 for all trials

Geographic Reach
4 countries

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2000

Completed
21 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 27, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 8, 2022

Completed
Last Updated

August 29, 2022

Status Verified

August 1, 2022

Enrollment Period

21 years

First QC Date

January 27, 2022

Last Update Submit

August 23, 2022

Conditions

Keywords

Glomerular filtration rateKidney transplantationEquationPrediction

Outcome Measures

Primary Outcomes (1)

  • Measured glomerular filtration rate (mGFR)

    Isotopic measurements of GFR

    Up to 15 years after kidney transplantation

Study Arms (8)

Development cohort

kidney transplant recipients in 3 centres in France: Necker, Saint-Louis and Toulouse hospitals

Other: No intervention

Validation cohort 1

kidney transplant recipients from Montpellier Hospital, France

Other: No intervention

Validation cohort 2

kidney transplant recipients from Lyon Hospital, France

Other: No intervention

Validation cohort 3

kidney transplant recipients from Tenon Hospital, France

Other: No intervention

Validation cohort 4

kidney transplant recipients from Saint-Etienne Hospital, France

Other: No intervention

Validation cohort 5

kidney transplant recipients from Mayo Clinic Hospital, USA

Other: No intervention

Validation cohort 6

kidney transplant recipients from Bergamo hospital, Italy

Other: No intervention

Validation cohort 7

kidney transplant recipients from Zagreb hospital, Croatia

Other: No intervention

Interventions

Kidney recipients aged over 18 and of all sexes recruited from 2000 who have mGFR follow-up and clinical, biological, and immunological data

Development cohortValidation cohort 1Validation cohort 2Validation cohort 3Validation cohort 4Validation cohort 5Validation cohort 6Validation cohort 7

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The development cohort consisted of kidney transplant recipients from 3 centres in France. The validation cohorts consisted kidney transplant recipients from 6 centers in Europe and 1 in the Unites states.

You may qualify if:

  • Living or deceased donor kidney recipient transplanted between 01/01/2000 and 01/01/2021.
  • Men or women over 18 years of age.
  • Written informed consent at the time of transplantation for the center database.

You may not qualify if:

  • Combined transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

William J. von Liebig Centre for Transplantation and Clinical Regeneration, Mayo Clinic

Rochester, Minnesota, United States

Location

Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School of Medicine, University of Zagreb

Zagreb, Croatia

Location

Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon

Lyon, France

Location

Department of Nephrology, Centre Hospitalier Universitaire, Montpellier

Montpellier, France

Location

Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris

Paris, France

Location

Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris

Paris, France

Location

Kidney Transplant Department, Tenon Hospital, Assistance Publique - Hôpitaux de Paris

Paris, France

Location

Nephrology, Dialysis and Renal Transplantation Department, Hôpital Nord, CHU de Saint-Etienne, Jean Monnet University, Université de Lyon

Saint-Etienne, France

Location

Department of Nephrology and Organ Transplantation, CHU Rangueil

Toulouse, France

Location

Istituto di Ricerche Farmacologiche Mario Negri IRCCS

Bergamo, Italy

Location

Related Publications (1)

  • Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prie D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L, Ibrahim HN, Nielsen MB, Matas AJ, Nankivell BJ, Benjamens S, Pol RA, Bakker SJL, Jouven X, Legendre C, Kamar N, Smith BH, Wadei HM, Durrbach A, Vincenti F, Remuzzi G, Lefaucheur C, Bentall AJ, Loupy A. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study. BMJ. 2023 May 31;381:e073654. doi: 10.1136/bmj-2022-073654.

Study Officials

  • Alexandre Loupy, MD, PhD

    Paris Translational Research Center for Organ Transplantation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 27, 2022

First Posted

February 8, 2022

Study Start

January 1, 2000

Primary Completion

January 1, 2021

Study Completion

January 1, 2021

Last Updated

August 29, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations